期刊
EMBO MOLECULAR MEDICINE
卷 11, 期 5, 页码 -出版社
WILEY
DOI: 10.15252/emmm.201708734
关键词
LHON; microRNA; miR-181; mitochondrial disease; neurodegeneration
资金
- Italian Fondazione Telethon [TGM16YGM02]
- Fondazione Roma [RP-201300000009]
- AFM-Telethon [20685]
- UniNA
- Compagnia di San Paolo (Bando STAR) [16-CSP-UNINA-048]
- MRC [MC_EX_MR/P007031/1, MC_UP_1002/1, MC_UU_00015/5] Funding Source: UKRI
Mitochondrial diseases (MDs) are a heterogeneous group of devastating and often fatal disorders due to defective oxidative phosphorylation. Despite the recent advances in mitochondrial medicine, effective therapies are still not available for these conditions. Here, we demonstrate that the microRNAs miR-181a and miR-181b (miR-181a/b) regulate key genes involved in mitochondrial biogenesis and function and that downregulation of these miRNAs enhances mitochondrial turnover in the retina through the coordinated activation of mitochondrial biogenesis and mitophagy. We thus tested the effect of miR-181a/b inactivation in different animal models of MDs, such as microphthalmia with linear skin lesions and Leber's hereditary optic neuropathy. We found that miR-181a/b downregulation strongly protects retinal neurons from cell death and significantly ameliorates the disease phenotype in all tested models. Altogether, our results demonstrate that miR-181a/b regulate mitochondrial homeostasis and that these miRNAs may be effective gene-independent therapeutic targets for MDs characterized by neuronal degeneration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据